3D-QSAR analysis of a new type of acetylcholinesterase inhibitors

被引:0
|
作者
AiLin Liu
HongMei Guang
LiYa Zhu
GuanHua Du
Simon M. Y. Lee
YiTao Wang
机构
[1] Chinese Academy of Medical Sciences and Peking Union Medical College,Institute of Materia Medica
[2] University of Macau,Institute of Chinese Medical Sciences
关键词
acetylcholinesterase (AChE); comparative molecular field analysis (CoMFA); phenyl pentenone derivatives;
D O I
暂无
中图分类号
学科分类号
摘要
Acetylcholinesterase (AChE) inhibitors are an important class of medicinal agents used for the treatment of Alzheimer’s disease. A screening model of AChE inhibitor was used to evaluate the inhibition of a series of phenyl pentenone derivatives. The assay result showed that some compounds displayed higher inhibitory effects. In order to study the relationship between the bioactivities and the structures, 26 compounds with phenyl pentenone scaffold were analyzed. A 3D-QSAR model was constructed using the method of comparative molecular field analysis (CoMFA). The results of cross-validated R2cv=0.629, non-cross-validated R2=0.972, SE=0.331, and F=72.41 indicate that the 3D-model possesses an ability to predict the activities of new inhibitors, and the CoMFA model would be useful for the future design of new AChE inhibitors.
引用
收藏
页码:726 / 730
页数:4
相关论文
共 50 条
  • [31] 3D-QSAR studies on fluroquinolones derivatives as inhibitors for tuberculosis
    Bhattacharjee, Atanu
    Mylliemngap, Baphilinia Jones
    Velmurugan, Devadasan
    BIOINFORMATION, 2012, 8 (08) : 381 - 387
  • [32] 3D-QSAR of sulfonamide hydroxamic acid HDAC inhibitors
    Liu, B
    Lu, AJ
    Liao, CZ
    Liu, HB
    Zhou, JJ
    ACTA PHYSICO-CHIMICA SINICA, 2005, 21 (03) : 333 - 337
  • [33] 3D-QSAR studies on malonyl coenzyme A decarboxylase inhibitors
    Patel, Maulik R.
    Talele, Tanaji T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (13) : 4470 - 4481
  • [34] Pharmacophore filtering and 3D-QSAR in the discovery of new JAK2 inhibitors
    Singh, Kh. Dhanachandra
    Karthikeyan, Muthusamy
    Kirubakaran, Palani
    Nagamani, Selvaraman
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2011, 30 : 186 - 197
  • [35] 3D-QSAR of CYP2A6 inhibitors
    Rahnasto, M.
    Wittekindt, C.
    Poso, A.
    Raunio, H.
    Juvonen, R. O.
    TOXICOLOGY LETTERS, 2005, 158 : S61 - S61
  • [36] 3D-QSAR and docking studies on pyridopyrazinones as BRAF inhibitors
    Yong Ai
    Shao-Teng Wang
    Chu Tang
    Ping-Hua Sun
    Fa-Jun Song
    Medicinal Chemistry Research, 2011, 20 : 1298 - 1317
  • [37] 3D-QSAR and docking studies on pyridopyrazinones as BRAF inhibitors
    Ai, Yong
    Wang, Shao-Teng
    Tang, Chu
    Sun, Ping-Hua
    Song, Fa-Jun
    MEDICINAL CHEMISTRY RESEARCH, 2011, 20 (08) : 1298 - 1317
  • [38] Docking studies and 3D-QSAR analysis for inducible nitric oxide synthase inhibitors
    Kyoya, Y
    Ueda, S
    Yano, A
    Tominaga, Y
    Ido, M
    Kawasaki, M
    Fujiwara, I
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U787 - U787
  • [39] CoMFA and CoMSIA 3D-QSAR analysis on hydroxamic acid derivatives as urease inhibitors
    Ul-Haq, Zaheer
    Wadood, Abdul
    Uddin, Reaz
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2009, 24 (01) : 272 - 278
  • [40] 3D-QSAR studies of farnesyltransferase inhibitors: A comparative molecular field analysis approach
    Puntambekar, D
    Giridhar, R
    Yadav, MR
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (07) : 1821 - 1827